Agbim Chisom, Fornari Marci, Willner Emily, Isbey Sarah, Berkowitz Deena, Palacious Katura, Badolato Gia, McIver Mandisa
From the Emergency Department, Children's Hospital Colorado, Aurora, CO.
Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
Pediatr Qual Saf. 2022 Sep 8;7(5):e589. doi: 10.1097/pq9.0000000000000589. eCollection 2022 Sep-Oct.
Anaphylaxis is a potentially fatal systemic reaction that requires prompt recognition and targeted treatment. Despite international consensus and national guidelines, there is often incomplete care for pediatric patients discharged from the emergency department (ED) with a diagnosis of anaphylaxis. Our institution experienced wide variability in discharge planning for patients with anaphylaxis. The goal of our study was to improve care at ED discharge for pediatric patients with anaphylaxis using a quality improvement framework. The specific aims were to increase the frequency of patients diagnosed with anaphylaxis who receive an anaphylaxis action plan at ED discharge from 0% to 60% and to increase referrals to an allergy clinic from a baseline of 61%-80% between October 2020 and April 2021.
Targeted interventions included revisions to the electronic health record system, forging interdisciplinary partnerships and emphasizing provider education. Outcome measures were the proportion of patients receiving an anaphylaxis action plan and an allergy clinic follow-up. The balancing measure was the ED length of stay.
The study showed an increase in anaphylaxis action plans from 0% to 34%. Allergy clinic referral rates improved from 61% to 82% within the same period. The average length of stay of 347 minutes remained unchanged.
Revising the discharge instructions to include an anaphylaxis action plan and reinforcing provider behaviors with educational interventions led to an overall improvement in discharge care for patients with anaphylaxis. Future work will focus on electronic health record changes to continue progress in additional clinical settings.
过敏反应是一种可能致命的全身性反应,需要迅速识别和针对性治疗。尽管有国际共识和国家指南,但对于急诊科(ED)诊断为过敏反应后出院的儿科患者,护理往往并不完善。我们机构对过敏反应患者的出院计划存在很大差异。我们研究的目的是使用质量改进框架改善急诊科对过敏反应儿科患者的出院护理。具体目标是将急诊科出院时接受过敏反应行动计划的过敏反应确诊患者的比例从0%提高到60%,并将2020年10月至2021年4月期间转诊至过敏诊所的比例从61%-80%的基线水平提高。
针对性干预措施包括修订电子健康记录系统、建立跨学科合作关系以及加强医务人员教育。结果指标是接受过敏反应行动计划和过敏诊所随访的患者比例。平衡指标是急诊科住院时间。
研究表明,过敏反应行动计划从0%增加到34%。同期过敏诊所转诊率从61%提高到82%。347分钟的平均住院时间保持不变。
修订出院指导以纳入过敏反应行动计划,并通过教育干预强化医务人员行为,总体上改善了过敏反应患者的出院护理。未来的工作将集中在电子健康记录的改变上,以在更多临床环境中持续取得进展。